In some studies, romidepsin has been reported to decrease levels of phospho-ERK in H-Ras-transformed cells and in cancer cell lines [17,21,23], whereas in others, no alterations in the levels of phospho-ERK in Ras-transformed cells were seen [24]. Here, MAPK1 is linked to cancer.